Skip to main content
. 2021 Jun 4;16(6):e0252353. doi: 10.1371/journal.pone.0252353

Table 3. Biochemical profiles.

Variables Without OSA With OSA P value
(n = 57) (n = 190)
Lipid Profile (mg/dl)
    Fasting blood glucose 93.7.69 ± 20.68 92.17 ± 23.35 0.3
    Total cholesterol 160.23 ± 35.39 151.68 ± 26.83 0.34
    Serum triglycerides 175.55 ± 125.09 106.13 ± 54.87 0.231
    HDL-C 45.6 ± 1.97 35.87 ± 6.85 0.092
    VLDL-C 35.21 ± 25.15 22.63 ± 11.37 0.284
Insulin markers
    Fating insulin (μU/ml) 8.2±3.2 10.4±2.3 0.03
    HOMA-IR 1.7±0.8 2.8±0.98 0.04
Liver enzymes (IU)
    ALT 26.58 ± 17.35 39.41 ± 34.39 0.003
    AST 27.5 ± 12.68 33.20 ± 16.70 0.09
    ALP 496.51 ± 204.34 589.59 ± 247.98 0.04
Other investigations
    Albumin (gm %) 4.74 ± 0.33 4.77 ± 0.45 0.792
    Bilirubin conjugated (mg %) 0.5666 ± 1.12 0.33333 ± .24 0.715
    Total Protein (gm %) 7.1063 ± 0.92 7.3464 ± 7.24 0.184
    Potassium (mEq/L) 135.85 ± 23.74 109.96 ± 56.86 0.026
    Creatinine (mg %) 0.52978 ± 0.12 0.45161 ± 0.95 0.004
    Urea (mg %) 26.92 ± 22.59 21.59 ± 5.88 0.21

All values are given as mean± standard deviation; n, number of subjects. HDL-C, high-density lipoprotein cholesterol; VLDL, very low-density lipoprotein; alanine transaminase, ALT; aspartate aminotransferase, AST, alkaline phosphate ALP, HOMA-IR, homoeostasis modal assessment for insulin resistance.